menu search

CPRX / Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference

Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference
CORAL GABLES, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that Patrick J. McEnany, Chairman and CEO of Catalyst, along with other members of the Catalyst's senior management team, will participate in the 2023 Cantor Global Healthcare Conference which will be held on September 26-28, 2023. Read More
Posted: Sep 18 2023, 08:03
Author Name: GlobeNewsWire
Views: 101961

CPRX News  

Catalyst Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 8, 2023

By GlobeNewsWire
October 23, 2023

Catalyst Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 8, 2023

The Company to Host a Conference Call and Webcast on November 9, 2023, at 8:30 AM ET The Company to Host a Conference Call and Webcast on November 9, more_horizontal

3 Solid Stocks to Buy for Superb Earnings Acceleration

By Zacks Investment Research
October 18, 2023

3 Solid Stocks to Buy for Superb Earnings Acceleration

Invest in stocks such as Catalyst Pharmaceuticals (CPRX), ImmunoGen (IMGN) and Inari Medical (NARI) for solid earnings acceleration. more_horizontal

Catalyst (CPRX) Seeks to Increase Maximum Daily Dose for Firdapse

By Zacks Investment Research
October 16, 2023

Catalyst (CPRX) Seeks to Increase Maximum Daily Dose for Firdapse

The FDA accepts Catalyst's (CPRX) sNDA to increase the indicated maximum daily dosage of Firdapse 10 mg from 80mg to 100mg for treating Lambert-Eaton more_horizontal

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

By Zacks Investment Research
October 12, 2023

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank. more_horizontal

New Strong Buy Stocks for October 11th

By Zacks Investment Research
October 11, 2023

New Strong Buy Stocks for October 11th

PBF, PRAX, CPRX, MFA and GFF have been added to the Zacks Rank #1 (Strong Buy) List on October 11, 2023. more_horizontal

4 Stocks That Exhibit Solid Earnings Acceleration

By Zacks Investment Research
October 6, 2023

4 Stocks That Exhibit Solid Earnings Acceleration

Invest in stocks like Catalyst Pharmaceuticals (CPRX), ImmunoGen (IMGN), Inari Medical (NARI) and Kyndryl Holdings (KD) for superb earnings accelerati more_horizontal

Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference

By GlobeNewsWire
September 18, 2023

Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference

CORAL GABLES, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutica more_horizontal

Why Is Catalyst (CPRX) Down 14% Since Last Earnings Report?

By Zacks Investment Research
September 8, 2023

Why Is Catalyst (CPRX) Down 14% Since Last Earnings Report?

Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? more_horizontal


Search within

Pages Search Results: